<DOC>
	<DOCNO>NCT00710190</DOCNO>
	<brief_summary>The purpose study demonstrate safety efficacy Rheos Baroreflex Hypertension Therapy System patient refractory hypertension .</brief_summary>
	<brief_title>Device Based Therapy Hypertension Trial</brief_title>
	<detailed_description>The DEBuT-HT trial investigate safety efficacy Rheos Baroreflex Hypertension Therapy ( TM ) patient refractory hypertension despite full pharmacologic therapy . Enrolled patient carefully assess prior receive permanently implant Rheos System . Once system implanted , patient follow closely 1 month establish baseline information . The Rheos System program `` ON '' 1 month follow-up incrementally increase 2 3-month follow-up evaluation . An assessment safety efficacy make 4-month follow-up . Enrolled patient follow annually thereafter .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Be least 21 year age . Have assess bilateral carotid bifurcation locate C3 C4 . Have blood pressure great equal 160 mmHg systolic and/or great equal 90 mmHg diastolic despite least two month full therapy least three ( 3 ) antihypertensive medication , least one ( 1 ) must diuretic . Must certify investigator compliant take full dos medication . Have sign approve informed consent form participation study . Have diagnose : Baroreflex failure significant orthostatic hypotension Cardiac brady arrhythmia chronic atrial fibrillation Have carotid atherosclerosis determine ultrasound angiographic evaluation stenosis great 50 % . Have prior surgery radiation either carotid sinus region Currently implant electrical medical device cardiac pacing , defibrillation neurologic stimulation system . Are pregnant contemplate pregnancy 4month followup period . Are dialysis Have hypertension secondary treatable cause Have clinically significant cardiac valvular disease Are unable comply protocol requirement . Are unlikely survive protocol followup period Are enrol another concurrent clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Drug Resistant Hypertension</keyword>
	<keyword>Refractory Hypertension</keyword>
	<keyword>High Blood Pressure</keyword>
	<keyword>Baroreflex Hypertension Therapy</keyword>
</DOC>